fulvestrant has been researched along with Insulin Resistance in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, ED; Brittain, EL; Chen, X; Farber-Eger, EH; Fessel, JP; Hemnes, AR; Loyd, JE; Talati, M; West, J | 1 |
| Bach, C; Baumert, TF; Brino, L; Crouchet, E; El Saghire, H; Garcia, T; Heydmann, L; Kopp, A; Pale, P; Pessaux, P; Schuster, C; Sureau, C; Turon-Lagot, V; Verrier, ER; Weiss, A; Zeisel, MB | 1 |
| Abderrahmani, A; Bosco, D; Cornu, M; Jacovetti, C; Jonas, JC; Laybutt, R; Meugnier, E; Parnaud, G; Peyot, ML; Prentki, M; Regazzi, R; Rome, S; Thorens, B | 1 |
3 other study(ies) available for fulvestrant and Insulin Resistance
| Article | Year |
|---|---|
Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.
Topics: Anastrozole; Animals; Bone Morphogenetic Protein Receptors, Type II; Disease Models, Animal; Echocardiography; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hemodynamics; Humans; Hypertension, Pulmonary; Insulin Resistance; Lung; Mice; Mice, Knockout; Mutation; Nitriles; Signal Transduction; Tamoxifen; Triazoles | 2017 |
Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets.
Topics: Antiviral Agents; Aspartate Carbamoyltransferase; Aspartic Acid; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cell Line; Dihydroorotase; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Fulvestrant; Gene Silencing; Hepatitis D, Chronic; Hepatitis Delta Virus; Hepatocytes; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin Resistance; Life Cycle Stages; Loss of Function Mutation; Phosphonoacetic Acid; Pyrimidines; RNA Interference; RNA, Small Interfering; RNA, Viral; Signal Transduction; Virus Replication | 2020 |
MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity.
Topics: Adaptation, Physiological; Animals; Cells, Cultured; Cytokines; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Insulin Resistance; Islets of Langerhans; Male; Mice; Mice, Mutant Strains; MicroRNAs; Obesity; Organ Size; Postpartum Period; Pregnancy; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Glucagon; Signal Transduction | 2012 |